These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF. Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078 [Abstract] [Full Text] [Related]
13. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530 [Abstract] [Full Text] [Related]
15. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort. Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW. J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319 [Abstract] [Full Text] [Related]
16. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758 [Abstract] [Full Text] [Related]
17. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. Laguna F, Rodríguez-Tudela JL, Martínez-Súarez JV, Polo R, Valencia E, Díaz-Guerra TM, Dronda F, Pulido F. Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134 [Abstract] [Full Text] [Related]
18. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF. Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454 [Abstract] [Full Text] [Related]
19. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S. Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443 [Abstract] [Full Text] [Related]
20. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, Morschhäuser J. Antimicrob Agents Chemother; 1998 Dec; 42(12):3065-72. PubMed ID: 9835492 [Abstract] [Full Text] [Related] Page: [Next] [New Search]